NCT05422963
Unknown
Not Applicable
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
ConditionsCOVID-19
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Ruijin Hospital
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- 28-day mortality
- Last Updated
- 3 years ago
Overview
Brief Summary
This study is to clarify the clinical characteristics of severe and critical COVID-19 from March 1st ,2022 to June 9th, 2022 in Shanghai and to explore the relationship between the characteristics and prognosis in these patients.
Detailed Description
1. To Describe the clinical characteristics of severe and critical COVID-19. 2. To analyze the relationship between the clinical characteristics and their clinical prognosis; 3. To analyze the relationship between clinical intervention and their clinical prognosis.
Investigators
Eligibility Criteria
Inclusion Criteria
- •severe and critical covid-19 patients who met the "Diagnosis and Treatment Plan for new Coronavirus Pneumonia (Ninth Edition)"
- •admission time more than 24 hours
Exclusion Criteria
- •admission time less than 24 hours
Outcomes
Primary Outcomes
28-day mortality
Time Frame: one year
28-day mortality of severe and critical COVID-19
Secondary Outcomes
- 60-day mortality(one year)
- the percentage of organ failure(one year)
- ICU length of stay(one year)
- time for virus to turn negative(one year)
- The overall description(one year)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.Chronic Lymphocytic LeukemiaIndolent B-Cell Non-Hodgkin LymphomaCOVID-19NCT05803395Gruppo Italiano Malattie EMatologiche dell'Adulto954
Completed
Not Applicable
COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2COVID-19NCT05268601University of Milano Bicocca251
Enrolling By Invitation
Not Applicable
Risk Identification of Long-term ComplicationsSevere COVID-19NCT06235866Wuhan Central Hospital500
Completed
Not Applicable
Analysis of Laboratory Markers for Severe COVID-19Coronavirus Infection COVID-19NCT06460753Karaganda Medical University193
Completed
Not Applicable
Predictors of Severe COVID-19 OutcomesAcute Respiratory Distress SyndromeCOVID-19NCT04388813Verily Life Sciences LLC494